薬物誘発性精神障害と統合失調症患者の症状の重症度と認知能力:横断的な比較研究
Kaloyan Stoychev1, Ivanka Veleva1, Eleonora Mineva-Dimitrova2
1Department of Psychiatry, Medical University and University Hospital Pleven, 113 Storgozia district, 5800 Pleven, Bulgaria.
Schizophrenia research. Cognition
|September 2, 2025
まとめ
薬物誘発性精神障害 (SIPD) と統合失調症 (SZ) は神経生物学的脆弱性を共有していますが,SZはより深刻な臨床的および認知障害を示しています. 両方の条件は,規範的なデータと比較して劣ったパフォーマンスを示しています.
科学分野:
- 神経科学
- 精神科
- 認知心理学
背景:
- 薬物誘発性精神障害 (SIPD) は懸念が高まっていますが,統合失調症 (SZ) との区別は不明です.
- SIPDとSZの患者の臨床および認知プロフィールを比較した以前の研究では,矛盾した結果が出ました.
研究 の 目的:
- SZとSIPDの患者の臨床的重症度と神経認知能力を比較する.
- 精神病の潜在的神経生物学的基盤を調査する
主な方法:
- 62人の参加者 (31人のSZ,31人のSIPD) の横断分析は,主要な人口統計で一致しました.
- 陽性・陰性症候群スケール (PANSS) を用いて臨床症状の評価
- 記憶,処理速度,注意力,認知の柔軟性,言語を含む神経認知機能の評価.
主要な成果:
- 統合失調症の患者は,ポジティブとネガティブな症状のPANSSスコアが著しく高かった.
- SZ患者は,セマンティックな記憶と言語を除いて,SIPD患者と比較して,ほとんどの領域でより大きな認知障害を示しました.
- SZとSIPDの両グループは,テストされたすべての認知領域において,標準値より著しく劣っていた.
結論:
- 発見はSIPDとSZの間の共通の神経生物学的な脆弱性を示唆しています.
- この脆弱性は統合失調症において 定量的により顕著であるようです
- この結果は,SIPDとSZが精神病のスペクトルに存在するかもしれないという考えを支持する.
関連する概念動画
Negative and Cognitive Symptoms of Schizophrenia
120
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
120
Positive Symptoms of Schizophrenia: Hallucinations and Delusions
216
Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
216
Positive Symptoms Schizophrenia: Hallucinations and Delusions
130
Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
Hallucinations
Hallucinations in...
130
Psychosis and Antipsychotic Drugs: Overview
453
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
453
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Schizophrenia
217
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
217


